A detailed history of Belvedere Trading LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Belvedere Trading LLC holds 1,548 shares of SMMT stock, worth $28,901. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,548
Previous 1,548 -0.0%
Holding current value
$28,901
Previous $33,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$6.89 - $31.93 $10,665 - $49,427
1,548 New
1,548 $33,000
Q4 2023

Feb 13, 2024

BUY
$1.67 - $2.83 $2,748 - $4,658
1,646 Added 18.3%
10,641 $27,000
Q3 2023

Oct 27, 2023

SELL
$1.54 - $2.42 $4,449 - $6,991
-2,889 Reduced 24.31%
8,995 $16,000
Q2 2023

Aug 08, 2023

BUY
$1.32 - $2.81 $6,382 - $13,586
4,835 Added 68.59%
11,884 $29,000
Q1 2023

May 15, 2023

BUY
$1.38 - $5.41 $9,727 - $38,135
7,049 New
7,049 $12,000

Others Institutions Holding SMMT

About Summit Therapeutics Inc.


  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.76B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.